2015 Oct 28
Targeting epigenetic switches may lead to novel therapies for B-cell lymphomas
Coverage of a presentation by Ari Melnick, M.D., at the recent Lymphoma & Myeloma 2015 meeting which featured many Weill Cornell organizers and investigators. Read more